News & Updates
Filter by Specialty:
Exenatide in acutefor stroke fails to improve neurological outcomes but helps manage blood sugar safely
In the treatment of patients with acute ischaemic stroke, treatment with exenatide does not appear to have any beneficial effect on neurological function at 7 days but is safe and substantially decreases the frequency of hyperglycaemic events, without leading to hypoglycaemia, according to the results of the phase II TEXAIS trial.
Exenatide in acutefor stroke fails to improve neurological outcomes but helps manage blood sugar safely
12 Dec 2023
Amivantamab-based regimens may alter EGFR-mutant NSCLC treatment paradigm in Asia
Updates from two MARIPOSA trials presented at ESMO Asia 2023 underpin the potential of amivantamab-based regimens for the treatment of locally advanced or metastatic EGFR-mutated non-small cell lung cancer (EGFRm NSCLC) in Asian subgroups.
Amivantamab-based regimens may alter EGFR-mutant NSCLC treatment paradigm in Asia
11 Dec 2023
Obesity persists in axSpA, especially in socially deprived patients
Obesity appears to be prevalent among patients with axial spondyloarthritis (axSpA) compared to the general population, according to a Swiss study, noting that socially disadvantaged individuals are most affected by this comorbidity.
Obesity persists in axSpA, especially in socially deprived patients
11 Dec 2023
One in six CYPs in SG develop long COVID
In Singapore, about one in six children and young persons (CYPs) developed long COVID, with persistence of ≥1 symptoms 3 months after an acute COVID-19 infection, a survey study suggests.
One in six CYPs in SG develop long COVID
11 Dec 2023
Light therapy associated with improved sleep and psychobehavioural symptoms in Alzheimer’s disease
A meta-analysis of 15 randomized controlled trials (RCTs) finds that light therapy significantly improves sleep efficiency, alleviates depression and reduces agitation in patients with Alzheimer’s disease (AD), as well as lessens caregiver burden.